#106

106 - The New Kids on the HIPAA Block: States’ Attorneys Generals Join the Party Thora Johnson, Partner, Orrick, Herrington Sutliffe LLP Debra Lightner, Chief Compliance Officer, EmblemHealth, Inc. Jaime Pego, Managing Director, KPMG LLP View Description

• In recent years, States' Attorneys General have begun to exercise their authority to enforce HIPAA. In 2018, the total number of state settlements exceeded the total number of federal settlements
• We will provide an overview of the life cycle of a State Attorney General action, along with recommendations for navigating the process and avoiding potential pitfalls
• We will also discuss how to leverage such a challenging situation and use it as an opportunity to improve your organization's overall privacy program and controls

Room 1

#206

206 - Merger and Acquisition: Compliance Due Diligence Isaac M Willett, Partner, Faegre Drinker Biddle & Reath Steve Lokensgard, Partner, Faegre Drinker Biddle & Reath View Description

• This session will briefly review the federal sentencing guidelines and help a small company understand whether a compliance program is voluntary or mandatory for your company
• Understand options for implementing an effective compliance program in a small company, and that one size does not fit all
• Understand some of the minimum expectations a large company will have with respect to compliance when acquiring a small, startup company

Room 2

#306

306 - Opioid Crisis: Big Pharma Got Us Here— Can Compliance Get Us Out? Cindy Hart, Compliance Professional Jackie Robertson-Gutshall, Compliance Officer , Advanced Regional Center for Ankle and Foot Care Chris Covington, Assistant Special Agent in Charge, HHS-Inspector General View Description

• Discuss when Big Pharma execs became aware of opioid abuses and what actions they took (or did not take). Let's talk about Project Tango
• Learn how various government agencies are working to combat the opioid crisis through litigation, education, and a host of government and state regulations
• Explore the role of compliance in the opioid crisis: From ethical sales campaigns, to PhRMA code adherence, to effective monitoring and auditing

Room 3

#406

406 - Beyond Checking the Box: Best Practices for Compliance Training Design, Delivery, and Evaluation Gregory Rider, Director, Corporate Compliance, EmblemHealth C.J. Wolf, Faculty, BYUI View Description

• Learn how a large healthcare entity has applied the principles of adult learning and technology to advance their training efforts
• Identify instructional design strategies and differences between in-person and online training approaches
• Explore methods for evaluating the effectiveness of training

Room 4

#107

107 - Managed Care Enforcement Trends and Compliance Risks John Kelly, Member, Bass, Berry & Sims PLC Sarah Kessler, Senior Counsel, Office of Inspector General, HHS Benjamin Singer, Partner, O’Melveny & Myers LLP View Description

• Review enforcement trends against Medicare and Medicaid managed care organizations and providers
• Key risk areas and best practices for minimizing exposure will be discussed to help identify and remediate compliance concerns
• Explain how compliance deficiencies in managed care processes and risk adjustment data create exposure under the false

Room 1

#207

207 - Auditing Ahead of the Auditors: A RAC, CERT, and TPE Prevention Program D. Scott Jones, Chief Compliance Officer, Augusta Health View Description

• Audit ahead of the RAC, CERT, and TPE audits and denials! Learn how to develop a pre-audit program designed to identify risks and improve processes before denials take place
• CMS and their contractors send signals about their audit targets. Learn how to identify the next wave of audits before they appear
• Turn compliance into a revenue center. Successful preparation leads to successful RAC, CERT, and TPE audits and appeals that retain or regain lost revenue

Room 2

#307

307 - Auditing the Trifecta: Compliance, Privacy, Security Debi Weatherford, Executive Director Internal Audit, Piedmont Healthcare Debra Muscio, SVP, Chief Audit, ERM, Privacy, Security, Ethics & Compliance Ofcr, Community Medical Centers View Description

• Rapid expansion and overlapping responsibilities in the trifecta of compliance, privacy, and security have impacted the risks and opportunities for collaboration. These area leaders will discuss risks that have an overarching role
• Provide updates on key regulations affecting the trifecta areas. Review key trends and risks associated with the areas and expanded opportunities for collaboration
• Discuss strategies for monitoring/auditing and effective governance and control processes. Evaluate self-monitoring and audit programs and strategies to perform self-reviews or independent audits

Room 3

#407

407 - We Cannot Make This Stuff Up: Tales of Non-compliance and Risk Management Susan Prior, Principal, BerryDunn Regina Alexander, Senior Manager & Director, IRO Services, BerryDunn View Description

• Through a series of sometimes extreme and other times humorous stories of good employees making poor decisions, costly errors, near misses, squabbles, and scandals, the presenters will discuss a variety of "hot" healthcare regulatory compliance and risk management challenges, as well as some new twists on some perennial favorites
• Risk mitigation strategies associated with the cases discussed, practical tips for surviving and thriving in a busy healthcare environment, and lessons learned will be shared with attendees
• Presenters will interact with the attendees and solicit input and questions to provide attendees with takeaways they can apply to their own tactical response to compliance and risk management challenges in their own organizations

Room 4

#108

108 - Medical Necessity & The False Claims Act: An Ever-Moving Target Christopher Melton, Partner, Wyatt, Tarrant & Combs LLP Rosalind Cordini, Senior Vice President, Coding & Compliance Services, Coker Group View Description

• The current way the False Claims Act is being used in litigation, with a focus on whether a doctor’s certification that a procedure is reasonable and necessary matches up with the government’s definition of the phrase
• Understand current False Claims Act case law for what must be alleged in order to deem medical necessity of a procedure/ service false, and learn from examples of recent FCA cases that are being filed
• Gain insight on various court decisions regarding the government’s burden in these cases, along with tangible advice on how to make sure that medical necessity is justified

Room 1

#208

208 - Compliance and the Board: Challenges and Best Practices Brian Annulis, Sr Managing Director, Ankura Consulting Group View Description

• Challenges to effective Board engagement
• Communicating with the Board: Education and reporting
• Continuing improvement: Further developing the compliance-Board connection

Room 2

#308

308 - How to Understand Information Security Risk for the Non-IT Professional Ken Satkunam, President, DueNorth Secure Healthcare Mark Schlader, Principal Partner, DueNorth Information Security Deanna Allen, Compliance, Privacy & Security Officer, Ivinson Memorial Hospital View Description

• Understand how to prioritize information security risks that have been identified through a risk analysis
• Learn how to work cohesively with IT to develop a risk management plan that everyone can understand, accept, and realistically accomplish
• Learn how to more effectively communicate information security risk and HIPAA security rule compliance to executive management and board members

Room 3

#408

408 - Auditing Compliance Effectiveness through a Lean Lens LaQuenta Clarke, Corporate Compliance Education Manager, Shriners Hospitals for Children International HQ View Description

• Establish two methodologies for developing an audit program for a compliance effectiveness review. Attendees will review programs for a well-established compliance program and a compliance program in its infancy stages
• Discuss the requirements for an effective compliance program and provide best practices for mitigating key risks in high areas of vulnerability based upon the compliance program’s maturity level
• Provide practical advice and tangible resources for incorporating lean methodologies into your compliance program practices

Room 4

#109

109 - Think Big. Think Small. Managing Conflict of Interest Nathan Perumal, Compliance Officer, Sutter Health View Description

• How do you manage potential COI for your organization? A discussion
• How to identify various potential COI scenarios for your organization? And for yourself?
• A roadmap to managing COI. Keep it simple for starters

Room 1

#209

209 - Remotely Speaking: Strategies for Effective Remote Employees and Their Employers Niurka Adorno-Davies, AVP Compliance, Molina Healthcare of South Carolina & Molina Healthcare of Puerto Rico Tomi Hagan, Chief Compliance Officer, Southeast Iowa Regional Medical Center Kym Creekmore, Compliance Officer View Description

• Oh so far, yet still so close: Optimizing the opportunities that remote employment provides
• Going the distance: Avoiding the pitfalls and compliance concerns with remote employment
• You don’' have to be there, to be there: Tools, tips, and tricks to keep everyone connected

Room 2

#309

309 - Top IT and Cyber Risks to Include in Your Audit Plan - 2020 Update Johan Lidros, President, Eminere Group View Description

• The use and deployment of information technology (IT) is a critical success factor for healthcare organizations. The speed of change, complexity and new requirements in the technology arena impact the ability to manage risk and ensure compliance
• In this session, participants will learn about the latest IT and cyber threats that can challenge their ability to deliver quality outcomes. They will learn how to best protect their data, ensure compliance and effectively monitor IT & cyber risks
• We will discuss best practices in IT Governance and help participants become better prepared for the latest IT audit challenges. This will include references to excepted industry standards

Room 3

#409

409 - The Laboratory Risk Assessment: The Process, the Top Risks, and What to Audit Andrea Treese Berlin, Senior Counsel, OIG-U.S. Department of HHS Barbara Senters, Chief Compliance & Ethics Officer, Sonic Healthcare USA, Inc. View Description

• Review risk assessment best practices to create multi-disciplinary teams to provide insight to vulnerabilities and to foster operational acceptance and implementation of compliance protocols into functional processes
• Discuss a deep dive of top laboratory fraud and abuse risks
• Discuss and receive suggested audit protocols to address lab risks as a basis for any laboratory compliance plan

Room 4

#110

110 - Boot Scootin’ Compliance Boot Camp: How to Lasso Your Leaders into Becoming Compliance Champions Shanna Luke, Compliance Programs Manager, Intermountain Healthcare Jordan Muhlestein, Compliance & Ethics Director, Intermountain Healthcare View Description

• Acquire a tool kit for creating a plan to engage leaders to become champions for addressing high-risk compliance issues
• Discuss practical methods to deliver education to executives and physicians
• Identify pitfalls inherent in education in a healthcare setting and suggestions of how to minimize them

Room 1

#210

210 - Compliance Essentials: Internal Investigations and Self-Disclosures Leia Olsen, Compliance Officer - Investigations & Incidents, Ascension Tamar Terzian, Senior Counsel, OIG/HHS Lori Wink, Attorney, Hall Render Killian Heath & Lyman P.C. View Description

• Understand the legal and practical considerations when deciding how and when to report compliance issues
• Learn the anatomy of a compliance investigation, including when to perform an audit, the goals of the review, the steps in conducting the investigation, corrective action and follow-up
• Identify key strategies for successfully coordinating investigations between the compliance department, in-house legal department, consultants and outside counsel

Room 2

#310

310 - Privacy Readiness: Do You Know Where Your PHI Lives with Medical Device Companies Kay Kay Chan, Director, PricewaterhouseCoopers Alison Brunelle, Director, PwC Jason Vendel, Sr. Mgr, Compliance Investigations & Global Privacy, Arthrex, Inc., View Description

• Privacy regulations and enforcement continue to rise. With the new California Consumer Privacy Act (CCPA), General Data Protection Regulation (GDPR), and HIPAA, scrutiny is placed on entities to create effective privacy programs
• This session will discuss a real life case study with a client who is a downstream privacy business associate of healthcare systems and provider groups
• Do you know what happens to the data? How do medical devices develop controls to support downstream HIPAA compliant regulations? What privacy efforts are put in place when medical devices are operating across different countries?

Room 3

#410

410 - 60-Day Repayment Rule: Discussion of Examples, Sampling Methods, and Strategies Tracy Field, Partner, Parker Hudson Rainer & Dobbs LLP View Description

• Developments in 60 day rule process- including new statistical sampling guidelines
• Review of hypotheticals for which no voluntary repayment indicated
• Review of hypotheticals, including sampling analysis/consideration where voluntary refund may be appropriate

• Advanced Session- developed for the compliance professional with 10+ years of experience

Room 4

#111

111 - Privacy Officer Round Table Adam Greene, Partner, Davis Wright Tremaine, LLP Joan Podleski, Chief Privacy Officer, Children's Health Marti Arvin, Executive Advisor, CynergisTek, Inc. View Description

• Highly interactive discussion of the most challenging privacy issues facing privacy officers and other privacy counsel and staff
• Audience members will select the privacy issues they would like to discuss, and will have the opportunity to learn from each other’s experience
• Obtain practical solutions from experts and peers on some of the toughest day-to-day health information privacy challenges

Room 1

#211

211 - Government Enforcement Kirk Ogrosky, Partner, Arnold & Porter Brandon Moss, Partner, Wiley Rein Amanda Strachan, Chief, Health Care Fraud Unit, United States Attorney's Office Miranda Hooker, Partner, Troutman Pepper Hamilton Sanders LLP View Description

• Learn what investigative tools are used by DOJ and HHS-OIG to initiate different types of investigations
• Best practices for addressing governmental investigations from hold notices, document collection and production, internal investigations, and resolution
• Understand the obligations of legal and compliance officers throughout an investigation

Room 2

#311

311 - Surviving as a Compliance Officer Wearing Multiple Hats Lisa Boston, AVP of Compliance, QHR Health View Description

• Per OIG Guidance, compliance programs should be scalable to the entity's size, but wearing multiple hats can be successful
• Different role scenarios and how to mitigate conflict of role
• Building relationships to make it work

Room 3

#411

411 - Health System Transformation, Fraud and Abuse Regulation, and Value-Based Purchasing: Rethinking Boundaries Jane Hyatt Thorpe, Program Director, The George Washington University Elizabeth Gray, Research Scientist, The George Washington University Milken Institute School of Public Health View Description

• Understand opportunities and challenges posed by the current legal framework governing healthcare fraud and abuse as applied to new delivery and payment models that rely on financial incentives to encourage cross-sector collaboration and integration
• Explore recent proposed changes to the existing healthcare fraud and abuse legal framework and evaluate whether and how these changes would better align the framework to the goals of a value-based payment system
• Identify themes and trends across proposed changes to the fraud and abuse framework and discover the next steps for compliance professionals navigating an uncertain environment

Room 4

#112

112 - The 340B Program: Perspectives on How to Promote Compliance in Your Covered Entity Michael Glomb, Partner, Feldesman Tucker Leifer Fidell LLP Coley Deal, 340B Program Manager, Bon Secours Mercy Health System, Inc. Sue Veer, CEO, Carolina Health Centers, Inc. View Description

• A CEO, a 340B program manager, a compliance officer, and an attorney will discuss how to address the Real-World compliance issues in the hospital and FQHC settings, including, applying the 340B patient definition across the continuum of care
• Responding to challenges in dispensing 340B drugs to Medicaid beneficiaries and in managed care in particular
• Monitoring for compliance, be ready for an audit 24/7, responding to new developments and OPA and other regulatory initiatives including current "hot topics"

Room 1

#212

212 - Managing Your Conflicts of Interest Process: Lessons from the IRS 990, Maryland Health System, Memorial Sloan Kettering, Michigan State, and the Physician Sunshine Act James Sheehan, Chief, Charities Bureau, NY Attorney General Roy Snell, ESG Officer, Author of IntegrityWorks, Co-founder of SCCE/HCCA, Osprey ESG Software View Description

• Conflict of Interest management-risks, disclosures, confidentiality, reputation
• Who should be responsible for managing conflicts of interest reporting and evaluation? What systems and processes should your organization have in place? How can you tell if they are working?
• Coming attractions in conflicts of interest: industry academic partnerships, IRS 990 data crawlers, Physician Sunshine Act, research integrity

• Advanced Session- developed for the compliance professional with 10+ years of experience

Room 2

#312

312 - Cybersecurity & Incident Response: The Nuts & Bolts of Avoiding and/or Responding to a Security Incident Scott Wrobel, Managing Member, N1 Discovery Debra Geroux, Shareholder, Butzel Long View Description

Room 3

#412

412 - The Role of Compliance in Government Enforcement: An Exploration of Recent Enforcement Activities, Evolution of Settlement Agreements, and Insights from a Corporate Monitorship Tamara Forys, Deputy Branch Chief, Office of Inspector General David Ogden, Partner, Wilmer Cutler Pickering Hale and Dorr LLP Shannon Sumner, Principal/Chief Compliance Officer, PYA View Description

• Recent policy changes demonstrating the DOJ's increased focus on compliance and a more pragmatic and common sense approach to enforcement will be explored and discussed, recognizing the value of an effective compliance program
• From the perspective of a former US Deputy Attorney General and corporate monitor, recent DOJ policy activities will be explored including their impact on corporation credit in False Claims Act cases
• This session will explore the evolution of settlement agreements, such as Corporate Integrity Agreements and Deferred Prosecution Agreements and the DOJ's and OIG's expectations for compliance with the terms of these agreements

Room 4

#113

113 - Be a HIPAA ACE: Awareness, Collaborate, and Educate Joseph Piccolo, VP Corporate Compliance, Inspira Health Dolores Baughman, Director, Inspira Health View Description

• Awareness begins at the top. Engage your senior leadership through accountability, audits and your annual workplan
• Collaborate with IT security, risk management, human resources, and legal to develop a strong focused infrastructure to support your efforts
• Educate using varied platforms to meet the needs of your workforce

Room 1

#213

213 - Measuring the Effectiveness of a Compliance Program Using the DOJ Guidance Joseph Zielinski, Of Counsel, Dinsmore & Shohl View Description

• Discussion and analysis of the three "fundamental questions" that according to the DOJ guidance should be asked to determine the effectiveness of a compliance program
• Attendees will see how the DOJ's guidance specifically calls out various elements associated with a compliance program and what questions are asked to further assess how well these elements are contributing to the effectiveness of a compliance program
• Attendees will have the opportunity to see and receive a tool that they can use to apply a data driven approach to assess how effectively their compliance programs align with the DOJ's guidance on the effectiveness of a compliance program

Room 2

#313

313 - Compli